Ertapenem does NOT cover Pseudomonas, but does still cover ESBL (main Fluoroquinolones - Ciprofloxacin (~70% coverage) Levofloxacin (~65%), NOT
If initial empiric therapy doesn't cover Pseudomonas, the pneumonia will Ceftriaxone does cover MSSA. This may be useful in various
Class. Name of Drug(s) Key Indications(s) Broadest activity of any antibiotic (does NOT cover MRSA, Mycoplasma, and some Pseudomonas) Clindamycin. Anaerobes
MRSA (see risk factors for MRSA); Pseudomonas (see Ceftriaxone does NOT cover Pseudomonas! Clindamycin; Metronidazole; Moxifloxacin; Tigecycline.
(MRSA). It is also active against Listeria monocytogenes and Enterococcus faecalis, but ceftaroline does not cover Pseudomonas aeruginosa.
negative coverage, non-suitable coverage of Pseudomonas. Broadest activity of any antibiotic (does NOT cover MRSA, Mycoplasma, and some Pseudomonas) Aztreonam.
Ertapenem does NOT cover Pseudomonas, but does still cover ESBL (main advantage is convenient once/day dosing - great outpatient IV drug). Other differences
Ertapenem does NOT cover Pseudomonas, but does still cover ESBL (main advantage Metronidazole (caution with Cipro due to poor strep coverage), or 3
Broadest activity of any antibiotic (does NOT cover MRSA, Mycoplasma, and some Pseudomonas) Clindamycin (bacteriostatic) Clindamycin. Anaerobes above the diaphragm.
Comments